Valuation: Illumina, Inc.

Market Cap 27.94B 24.49B 22.64B 20.82B 39.28B 2,694B 39.92B 271B 106B 1,318B 105B 103B 4,542B P/E 2026 *
39.4x
P/E 2027 * 32.4x
Enterprise Value 28.43B 24.92B 23.04B 21.19B 39.98B 2,742B 40.62B 275B 108B 1,342B 107B 104B 4,622B EV / Sales 2026 *
6.22x
EV / Sales 2027 * 5.74x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.06%
1 week-2.83%
Current month+5.03%
1 month+14.05%
3 months+39.00%
6 months+25.49%
Current year+40.81%
1 week 183.74
Extreme 183.745
191.87
1 month 158.91
Extreme 158.91
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

167 0.0001%
6/30/26 Free

Director

142 0.0001%
6/30/26
Corvex Management LP
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-2.83%+92.09%+0.28% 27.94B
-1.17%-0.43%+26.88%-2.24% 196B
-1.33%+0.47%+5.82%-17.71% 142B
+2.24%-13.25%-31.90%+1.58% 125B
-0.59%-1.97%-57.77%-18.13% 65.06B
-0.85%-7.40%+11.13%-8.26% 48.94B
-1.68%+1.25%-24.19%-32.37% 44.9B
-0.91%-2.82%+14.27%+4.58% 36.79B
-3.10%-4.20%+24.35%+27.80% 35.11B
-0.19%+0.06%-23.00%-9.43% 28.65B
Average -1.22%-3.17%+3.77%-5.39% 75.04B
Weighted average by Cap. -1.22%-2.97%+1.45%-6.55%

Financials

2026 *2027 *
Net sales 4.57B 4.01B 3.7B 3.41B 6.43B 441B 6.53B 44.28B 17.36B 216B 17.16B 16.79B 743B 4.83B 4.23B 3.91B 3.6B 6.79B 466B 6.9B 46.8B 18.35B 228B 18.14B 17.74B 785B
Net income 723M 634M 586M 539M 1.02B 69.76B 1.03B 7.01B 2.75B 34.14B 2.72B 2.66B 118B 871M 764M 706M 649M 1.23B 84.04B 1.24B 8.44B 3.31B 41.12B 3.27B 3.2B 142B
Net Debt 492M 431M 398M 366M 691M 47.4B 702M 4.76B 1.87B 23.19B 1.85B 1.81B 79.9B -222M -194M -179M -165M -311M -21.36B -316M -2.15B -841M -10.45B -832M -814M -36.01B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-07-20 $184.68 -1.06% 1,497,335
26-07-17 $186.65 -1.89% 1,251,212
26-07-16 $190.25 +1.66% 1,140,846
26-07-15 $187.15 -2.12% 1,782,478
26-07-14 $191.20 +0.61% 1,994,908
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
184.68USD
Average target price
169.47USD
Spread / Average Target
-8.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock